Lyora Therapeutics
Belmont, US · Founded 2024 · Delaware corporation
Find your way into Lyora Therapeutics
Sign up to see every warm intro you have to Lyora Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lyora Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
LV
Luc Vandenberghe, PhDNamed on SEC filing
Board
EP
Eric Pierce, MD, PhDBoard director
Funding
SEC filings, press & company announcements$525K disclosed across 1 of 2 rounds · 2025–2026
- Undisclosed amountSeedJul 2026 · 3 sourcesSource ↗
▶$525KraisedMar 2025 · 4 investors · BiotechnologyRule 506(b)
▶$525KraisedMar 2025 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Luc Vandenberghe, PhDExecutive Officer, Director
- Eric Pierce, MD, PhDDirector
- Offering amount
- $2M
- Amount sold
- $525K
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Lyora Therapeutics raised?
- Lyora Therapeutics has disclosed $525K raised across 1 of its 2 known rounds.
- Where is Lyora Therapeutics headquartered?
- Lyora Therapeutics is headquartered in Belmont, US.